Navigation Links
ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride
Date:8/4/2009

EXTON, Pa., Aug. 4 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that the Pharmaceutical Science and Clinical Pharmacology Advisory Committee supports the FDA's Office of Generic Drugs (OGD) draft guidelines on bioequivalence (BE) for Vancocin(R) (vancomycin hydrochloride) capsules. Vancocin is used to treat severe, often life-threatening bacterial infections of the gastrointestinal (GI) tract, Clostridium difficile infection (CDI) and enterocolitis caused by Staphylococcus aureus. The draft guidelines, if approved, would allow generic manufacturers to use less rigorous standards, including in vitro rather than in vivo testing, for establishing BE rather than using comparative clinical trials. ViroPharma scientists and other leading experts voiced their concern that these new guidelines could jeopardize patient safety.

"We're appreciative that the FDA convened this advisory committee to provide a forum for open debate and discussion regarding a serious public health issue," said Vincent J. Milano, ViroPharma's president and chief executive officer. "While we're disappointed with the vote, we hope that the OGD will take every precaution to ensure that CDI patients will be treated with truly bioequivalent versions of vancomycin, given the life-threatening nature of the disease."

The Advisory Committee was asked if the proposed OGD guidelines and the use of in vitro dissolution methods are sufficient for establishing bioequivalence for generic vancomycin oral capsules. The Advisory Committee voted unanimously in favor of the proposed OGD recommendation to demonstrate bioequivalence through equivalent dissolution in media of pH 1.2, 4.5 and 6.8 for potential vancomycin HCl capsule
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
2. ViroPharma to Release 2009 Second Quarter Financial Results on July 29, 2009
3. ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
4. ViroPharma Announces Meeting of FDA Advisory Committee for Pharmaceutical Science and Clinical Pharmacology on Bioequivalence Recommendations for Oral Vancomycin Hydrochloride Products
5. ViroPharma to Present at Two May Healthcare Conferences
6. ViroPharma to Present at the Cowen & Company 29th Annual Healthcare Conference
7. ViroPharma to Host Investor Teach-In Educational Symposium on Hereditary Angioedema
8. ViroPharma to Release 2008 Fourth Quarter and Full Year Financial Results on February 24, 2009
9. ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
10. ViroPharma to Present at the 27th Annual J.P. Morgan Healthcare Conference
11. ViroPharma Provides Update on Vancocin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Prevention is the best treatment for the Enterovirus ... children and teenagers in 12 states, including nearby Oklahoma ... Legacy ER & Urgent Care (LER) in Frisco, Texas. ... EV-D68 so far in North Texas, but with it ... “Implementing prevention strategies now may help keep any outbreak ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 The Food ... today, September 17, 2014, to consider: , ... Therapy (TRT), and, 2. The potential ... , With the TRT litigation ongoing, an informally-organized litigation ... the dangers of testosterone replacement therapy. Among others, ZKB ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 A petition ... ) in laparoscopic hysterectomies and other gynecological surgeries has ... to figures posted on Change.org, at least 84,908 supporters ... , According to a recent report from ABC News, ... by Dr. Hooman Noorchashm, after his wife, Dr. Amy ...
(Date:9/17/2014)... The Delta Dental Community Care Foundation announced today ... Health Foundation: America’s ToothFairy (NCOHF) to support oral health ... Zone Program® in California. , The Orange County NCOHF ... local constituent groups and stakeholders in a comprehensive approach ... its devastating effects on local families. The support of ...
(Date:9/17/2014)... HealthDay Reporter WEDNESDAY, Sept. 17, ... to explain why antibiotic-resistant bacteria can thrive in a hospital ... to be the culprit. They can easily enter bacteria and ... gene that makes bacteria drug-resistant, a new study finds. ... to a class of antibiotic called carbapenems," said the study,s ...
Breaking Medicine News(10 mins):Health News:Legacy ER & Urgent Care Warns North Texans about Dangers of Enterovirus D68 2Health News:FDA Advisory Committee Holds Hearing on Testosterone Safety 2Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Petition Nears 85,000 Signatures, Bernstein Liebhard LLP Reports 4Health News:Delta Dental Community Care Foundation Donation to America's ToothFairy Helps Deliver Critical Services 2Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 2Health News:Researchers Discover How Bacteria Resist Antibiotics in Hospitals 3
... severe injuries on battlefields such as those in Iraq ... of their wounds with multidrug resistant bacteria. The potentially ... Staphylococcus aureus (MRSA), Acinetobacter baumannii , ... . , Dr Clinton K. Murray, from Brooke Army ...
... by 43 percent, study found , , SUNDAY, March 29 ... incidence of heart attacks and stroke, the cholesterol-lowering drug ... rate of blood clots in the veins, new research ... presented Sunday at the American College of Cardiology annual ...
... caution , , SUNDAY, March 29 (HealthDay News) -- Springtime for ... if they,re not careful, it might also bring a trip ... and lawn mowers alone cause hundreds of thousands of injuries ... Consumer Product Safety Commission. Many of these household accidents are ...
... urges first responders to clean equipment regularly with ... -- One in three stethoscopes used by U.S. ... Staphylococcus aureus (MRSA) bacteria, a new study suggests. ... Dentistry of New Jersey swabbed 50 stethoscopes used ...
... caregivers, patients and their families joined television stars and ... the third annual National Walk for Epilepsy. Over the ... $2 million dollars and engaged more than 13,000 walkers. ... Money raised from the Walk helps create much needed ...
... drug warfarin for many patients, researchers say, , , SATURDAY, ... soon replace the anti-clotting drug warfarin as the first ... a new study suggests. , People with atrial fibrillation ... noted, and typically need to take warfarin for the ...
Cached Medicine News:Health News:Statin Might Help Fight Blood Clots in Veins 2Health News:Statin Might Help Fight Blood Clots in Veins 3Health News:Tips to Avoid Spring Cleaning Mishaps 2Health News:Third of EMS Stethoscopes Carry MRSA Bacterium 2Health News:Video: Celebrities and Thousands of Walkers Unite at Nation's Capitol to Raise Awareness About Seizures and Epilepsy 2Health News:Video: Celebrities and Thousands of Walkers Unite at Nation's Capitol to Raise Awareness About Seizures and Epilepsy 3Health News:New Device Treats Common Heart Rhythm Disorder 2Health News:New Device Treats Common Heart Rhythm Disorder 3
(Date:9/17/2014)... -- According to a new market research ... Device, Display, & Microprocessor/MCU), by Application (Imaging, Medical Therapeutics, ... - Global Forecast to 2020", published by MarketsandMarkets, the ... reach $56.50 Billion by 2020, growing at a CAGR ... 235 market data Tables and 71 Figures spread through ...
(Date:9/17/2014)... Sept. 17, 2014  The law firm McElroy, ... that it will serve as host for "Show ... the Risks of Healthcare Reform," a one-day conference ... delivery systems, reimbursement, compliance and enforcement in a ... Logo -  http://photos.prnewswire.com/prnh/20140916/146606 Logo -  ...
(Date:9/17/2014)... , Sept. 17, 2014   GS1 US ... to implement GS1 Standards to support the 2013 ... patient safety and security in the pharmaceutical supply ... Standards to U.S. Pharmaceutical Supply Chain Business Processes ... , was developed in collaboration with GS1 ...
Breaking Medicine Technology:Medical Electronics Market Worth $56.50 Billion by 2020 2Medical Electronics Market Worth $56.50 Billion by 2020 3Medical Electronics Market Worth $56.50 Billion by 2020 4Three Leading Healthcare Organizations Sponsor Conference to Examine Opportunities and Risks of Healthcare Reform for Providers 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 3New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 4
... Inc. (OTC: HEWA) a leading VIPPS accredited retail mail-order ... ended June 30, 2011. For the ... increased $753,059 to $2,519,721, up 43% compared to the ... in the Company,s prescription business. Prescriptions filled increased from ...
... in global nutrition.  Abbott expects to increase its nutrition revenues ... end of 2014. China also continues to be an important part ... the year, more than 26 percent of Abbott,s global sales ... Nutrition,s global sales were in emerging markets. ...
Cached Medicine Technology:HealthWarehouse.com Reports 43% Revenue Growth Year-Over-Year 2Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market 2
ENDOlap™ laparoscopes provide excellent image linearity and flatness of field....
Inquire...
The Fujinon's R410 laparoscope is the first to bring a 410,000 pixel CCD to the end of the scope. Superior imaging and color replication, along with a unique lens washing capability make the R410 the...
ACMI™ Distortion-Free Laparoscopes utilize technical advances in optical lens design to provide images without the fish-eye effect typically found on the peripheral viewing edges of conventional...
Medicine Products: